Sugammadex-Mepha 200 mg/2 ml
Sugammadex-Mepha 200 mg/2 ml is a medicine authorised by Swissmedic under authorisation number 69000. The authorisation holder is Mepha Pharma AG. The medicinal product code is Antidotes and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 July 2023 and the authorisation is limited until 20 July 2028. ATC code V03AB35 places the medicine in the group All other therapeutic products.
| Authorisation number | 69000 |
|---|---|
| Name | Sugammadex-Mepha 200 mg/2 ml |
| Full name | Sugammadex-Mepha 200 mg/2 ml, Injektionslösung |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Antidotes |
| Dispensing category | B · Prescription only |
| ATC code | V03AB35 |
| First authorisation | 21 July 2023 |
| Authorisation validity | 20 July 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sugammadex-Mepha 200 mg/2 ml, Injektionslösung | B | 21 July 2023 |
| 2 | Sugammadex-Mepha 500 mg/5 ml, Injektionslösung | B | 21 July 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Durchstechflasche(n) | V03AB35 | 15.01.0. | B |
| 2 | 10 | Durchstechflasche(n) | V03AB35 | 15.01.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sugammadex-Mepha 200 mg/2 ml authorised in Switzerland?
Yes. Sugammadex-Mepha 200 mg/2 ml is authorised by Swissmedic under authorisation number 69000, data as of 01 September 2026. The authorisation is limited until 20 July 2028.
Which dispensing category does Sugammadex-Mepha 200 mg/2 ml have?
Sugammadex-Mepha 200 mg/2 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sugammadex-Mepha 200 mg/2 ml?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.